Biomedical HIV prevention – the social complexities of achieving effectiveness

This article by NAM aidsmap gives highlights from a session of the 2nd International Conference for the Social Sciences and Humanities in HIV, held in Paris in July.

The session included presentations by leading scholars including Professor Susan Kippax, 2013 conference chair.

The debate focused on the need to engage with 'real-world conditions' when assessing the potential of biomedical interventions to prevent HIV. If gaps in the treatment cascade are not accounted for, scholars argued, there remains a risk of over-stating and over-simplifying the effectiveness of interventions such as treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP).

A summary of the session plus links to relevant presentations is available here.


Filter by